Raffaele Colombo
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Raffaele Colombo
May 13, 2024, 14:12 |
Blog
Raffaele Colombo: Personal selection of 30 new ADCs that will be presented at ASCO24
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: "Personal selection of…
Apr 9, 2024, 12:53 |
Blog
Christiana Bardon: The AACR industry partnering event was a tremendous success
Christiana Bardon, Co-Managing Partner at MPM BioImpact, shared on their LinkedIn: ''The American Association for…
Apr 8, 2024, 15:15 |
Blog
Raffaele Colombo: AACR Annual Meeting 2024 has started!
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on LinkedIn: "AACR Annual Meeting…
Mar 21, 2024, 17:13 |
Blog
Raffaele Colombo: It was such an honor and a pleasure to open the DAVA Oncology Think Tank on Antibody Drug Conjugates and Bispecifics meeting in Victoria
Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks Inc., recently posted on…
Feb 22, 2024, 18:56 |
Blog
Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial
Raffaele Colombo, Principal Scientist & Group Lead, Medicinal Chemistry at Zymeworks, shared on X/Twitter: "Application based…
Jan 24, 2024, 22:30 |
Insight
Raffaele Colombo: Evoke-01 study of sacituzumab govitecan (SG) did not meet its primary overall survival goal in patients with NSCLC
Raffaele Colombo, Principal Scientist at Zymeworks, shared on X: "Evoke-01 study of sacituzumab govitecan (SG)…
Nov 15, 2023, 17:08 |
History
Raffaele Colombo: Can you believe these were written almost 40 years ago?
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute shared a post on Twitter by…
Nov 4, 2023, 00:58 |
Drugs
Raffaele Colombo: Here the breakdown of the Monomethyl auristatin E Antibody Drug Conjugates
Raffaele Colombo, Principal Scientist at Zymeworks, shared on X/Twitter: 106 auristatin Antibody Drug Conjugates (ADCs)…
Oct 16, 2023, 23:06 |
Opinion
Paolo Tarantino: Greatly enjoyed contributing to the ADC session at Targets23!
Paolo Tarantino, MD and Researcher at the European Institute of Oncology and Clinical Research Fellow at…
Oct 14, 2023, 22:16 |
Blog
Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter: "So…
1
2
All:
14
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube